Pangenomic Health Inc. NARA
CNSX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -2.16% | 0.31% | |||
| Gross Profit | 2.16% | -0.31% | |||
| SG&A Expenses | -41.52% | 17.24% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -39.53% | 16.25% | |||
| Operating Income | 39.53% | -16.25% | |||
| Income Before Tax | 27.50% | -6.53% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 27.50% | -6.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 27.50% | -6.53% | |||
| EBIT | 39.53% | -16.25% | |||
| EBITDA | 39.53% | -16.25% | |||
| EPS Basic | 27.69% | -7.44% | |||
| Normalized Basic EPS | 27.61% | -7.95% | |||
| EPS Diluted | 27.69% | -7.44% | |||
| Normalized Diluted EPS | 27.61% | -7.95% | |||
| Average Basic Shares Outstanding | 0.00% | -0.85% | |||
| Average Diluted Shares Outstanding | 0.00% | -0.85% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||